Skip to main content
Equibles
AZTA logo

AZTA · Azenta, Inc. · Metrics

Track AZTA — free

Use AZTA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AZTA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$35.73 +0.89 (+2.55%) At close · Oct 20
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.59B
Shares
43.81M
Volume · Oct 20 769.89K Avg daily vol (3M) 925.66K

AZTA metrics

93 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$35.73
Market cap
$1.59B

Price action

20 metrics
Price change (1W)
-5.7%
Price change (30D)
+5.9%
Price change (3M)
+34.4%
Price change (6M)
+36.0%
Price change (YTD)
+7.4%
Price change (1Y)
+13.2%
Trailing year
Price change (5Y)
-66.4%
52-week high
$42.73
52-week low
$16.02
Change from 52-week high
-16.4%
Change from 52-week low
+123.0%
Annualized volatility
63.2%
Annualized volatility (3M)
61.4%
Beta
1.5
RSI (14D)
51.1
Price vs SMA 50
+4.2%
Price vs SMA 200
+26.1%
Avg volume (3M)
925,658
Relative volume
0.8
Average dollar volume
$31.51M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
43.81M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.6×
reciprocal yield 38.7%
P / book
1.1
reciprocal yield 95.2%
FCF yield
0.6%
TTM · current market cap
Buyback yield
3.2%
P / FCF
160.6
reciprocal yield 0.6%
P / operating cash flow
41.8
reciprocal yield 2.4%
Earnings yield
-7.7%

Historical valuation

8 metrics
P / E historical average (3Y)
32.4×
reciprocal yield 3.1%
P / E historical average (5Y)
30.3×
reciprocal yield 3.3%
EV / revenue historical average (3Y)
7.6×
reciprocal yield 13.2%
EV / revenue historical average (5Y)
7.6×
reciprocal yield 13.2%
EV / EBIT historical average (3Y)
54.0×
reciprocal yield 1.9%
EV / EBIT historical average (5Y)
54.0×
reciprocal yield 1.9%
EV / EBITDA historical average (3Y)
84.0×
reciprocal yield 1.2%
EV / EBITDA historical average (5Y)
84.0×
reciprocal yield 1.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
44.0%
Operating margin
-28.6%
Trailing 12 months
Net margin
-20.0%
Gross profit (TTM)
$270.37M
Operating profit (TTM)
−$175.30M
Net income (TTM)
−$122.90M
Trailing 12 months
Diluted EPS (TTM)
$-2.67
FCF margin
1.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$13.40
Gross profit per diluted share (TTM)
$5.90
Operating profit per diluted share (TTM)
$-3.81
EBITDA per diluted share (TTM)
$-2.59
Net income per diluted share (TTM)
$-2.67
Operating cash flow per diluted share (TTM)
$0.83
Free cash flow per diluted share (TTM)
$0.21
Capital expenditures per diluted share (TTM)
$0.61
R&D per diluted share (TTM)
$0.78
Stock compensation per diluted share (TTM)
$0.42
Book value per share
$37.66

Growth

11 metrics
Revenue growth YoY
+12.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$613.81M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-1.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.2%
Revenue CAGR (5Y)
+8.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-8.1%
Return on assets
-6.6%
Debt / equity
—
Current ratio
2.5
EBITDA (TTM)
−$119.64M
Free cash flow (TTM)
$9.88M
Quick ratio
2.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$189.65M
Total assets
$1.88B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$37.98M
Capital expenditures (TTM)
$28.09M
R&D (TTM)
$35.73M
SG&A (TTM)
$257.38M
Stock compensation (TTM)
$19.40M
R&D / revenue
5.8%
Stock compensation / revenue
3.2%

Ownership (13F)

9 metrics
13F filers
250
13F filer change QoQ
-12
Institutional ownership
115.6%
Conviction holders (share of 13F filers)
1.2%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-15.7%
Holder tenure
13.1
Price vs estimated holder cost
-29.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
27.8%

Short interest

3 metrics
Short interest
12.1%
Latest settlement · 6.1 days to cover
Days to cover
6.1d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
$8,096
Insider-sentiment score
73 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 933974 CUSIP 114340102 13F (30d) 32 filings 30 filers Visit website Investor relations